-
Healthy Habits
Antioxidant ProtectionTomatoes might play a role in decreasing a man's risk of prostate cancer.
by Leigh Labrie
-
Q&A
Paying Attention to DepressionPsychiatrist Michael Sharpe suggests a new approach to identifying and treating depression in cancer patients.
by Marci A. Landsmann
-
Healthy Habits
Take a StandSitting might increase risk for colon and endometrial cancers.
by Leigh Zaleski
-
Q&A
Changing BehaviorJohn P. Pierce highlights the role of public health campaigns in cutting cancer risk.
by Susan FitzGerald
-
Editor's Letter
Eat to LiveManaging your weight can help reduce your risk for cancer or cancer recurrence.
by Kevin McLaughlin
-
Forward Look
Eating WellWalter Willett believes research will show that a healthy diet can reduce cancer risk. Here's why.
by Sue Rochman
-
Forward Look
Deciphering New Rates of Thyroid CancerExperts are divided on whether the increase is due to more cancer or more diagnoses.
by Melissa Weber
-
Forward Look
Burned by the SunStudy links five or more blistering sunburns during adolescence to increased adult melanoma risk.
by Marilyn Fenichel
-
Forward Look
Double Mastectomies on the RiseStudy suggests fears rather than actual risk of recurrence drive decisions.
by Cameron Walker
-
Forward Look
Exploring the Link Between Cancer and Vitamin DQuestions remain about low vitamin D levels and cancer risk.
by Sharon Reynolds
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
